203 related articles for article (PubMed ID: 33828526)
21. [Genetic analysis of a family with Von Hippel-Lindau syndrome].
Lafuente-Sanchis A; Cuevas JM; Alemany P; Cremades A; Zúñiga Á
Rev Esp Patol; 2017; 50(1):64-67. PubMed ID: 29179968
[TBL] [Abstract][Full Text] [Related]
22. Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis.
Negro A; Graiani G; Nicoli D; Farnetti E; Casali B; Verzicco I; Tedeschi S; Ghirarduzzi A; Cannone V; Marco LDE; Filice A; Gemelli G; Giunta A; Cabassi A
J Hypertens; 2020 Feb; 38(2):340-346. PubMed ID: 31568062
[TBL] [Abstract][Full Text] [Related]
23. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
24. Familial isolated pheochromocytoma presenting a new mutation in the von Hippel-Lindau gene.
Sansó G; Rudaz MC; Levin G; Barontini M
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1107-11. PubMed ID: 15607616
[TBL] [Abstract][Full Text] [Related]
25. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
[TBL] [Abstract][Full Text] [Related]
26. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
[TBL] [Abstract][Full Text] [Related]
27. Antiproliferative effects of metformin in cellular models of pheochromocytoma.
Meireles CG; Lourenço de Lima C; Martins de Paula Oliveira M; Abe da Rocha Miranda R; Romano L; Yo-Stella Brashaw T; Neves da Silva Guerra E; de Assis Rocha Neves F; Chapple JP; Simeoni LA; Lofrano-Porto A
Mol Cell Endocrinol; 2022 Jan; 539():111484. PubMed ID: 34637881
[TBL] [Abstract][Full Text] [Related]
28. Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma.
Meyer-Rochow GY; Smith JM; Richardson AL; Marsh DJ; Sidhu SB; Robinson BG; Benn DE
J Surg Res; 2009 Nov; 157(1):55-62. PubMed ID: 19215943
[TBL] [Abstract][Full Text] [Related]
29. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
30. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
Kaelin WG
Cold Spring Harb Symp Quant Biol; 2005; 70():159-66. PubMed ID: 16869749
[TBL] [Abstract][Full Text] [Related]
31. von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.
Miyagawa Y; Nakazawa M; Noda Y; Ito S; Ohguro H
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):241-4. PubMed ID: 12644949
[TBL] [Abstract][Full Text] [Related]
32. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
[TBL] [Abstract][Full Text] [Related]
33. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.
Rich TA; Jonasch E; Matin S; Waguespack SG; Gombos DS; Santarpia L; Stolle C; Jimenez C
Cancer Invest; 2008 Jul; 26(6):642-6. PubMed ID: 18584357
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
35. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
[TBL] [Abstract][Full Text] [Related]
36. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of the Von Hippel-Lindau (VHL) gene in a family with non-syndromic pheochromocytoma: the importance of genetic testing.
Cruz JB; Fernandes LP; Clara SA; Conde SJ; Perone D; Kopp P; Nogueira CR
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1463-7. PubMed ID: 18209888
[TBL] [Abstract][Full Text] [Related]
38. [Genetic detection and analysis of the VHL gene in patients with sporadic pheochromocytoma].
Zhang B; Wang YM; Wang N; Ha XQ; Dong YC; Zhou DH
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):361-5. PubMed ID: 19799085
[TBL] [Abstract][Full Text] [Related]
39. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
[TBL] [Abstract][Full Text] [Related]
40. [Mutation screening of VHL gene in a Chinese family with nonsyndromic pheochromocytoma].
Zhou DH; Wang YM; Lan T; Dong YC; Zhang B; Li WP; Ma WQ; Chang DH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):365-8. PubMed ID: 17680521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]